Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2010 1
2012 3
2014 1
2015 6
2016 10
2017 12
2018 4
2019 6
2020 11
2021 6
2022 3
2023 7
2024 1
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
The tumor suppressor HNRNPK induces p53-dependent nucleolar stress to drive ribosomopathies.
Aguilar-Garrido P, Velasco-Estévez M, Navarro-Aguadero MÁ, Otero-Sobrino Á, Ibáñez-Navarro M, Marugal MÁ, Hernández-Sánchez M, Malaney P, Rodriguez A, Benitez O, Zhang X, Aitken MJ, Ortiz-Ruiz A, Megías D, Pérez M, Mata G, Gomez J, Lafarga M, Domínguez O, Graña-Castro O, Caleiras E, Ximénez-Embun P, Isasa M, de Andres PJ, Rodríguez-Perales S, Torres-Ruiz R, Revilla E, García-Martín RM, Azorín D, Zubicaray J, Sevilla J, Sirozh O, Lafarga V, Martínez-López J, Post SM, Gallardo M. Aguilar-Garrido P, et al. Among authors: hernandez sanchez m. J Clin Invest. 2025 May 8;135(12):e183697. doi: 10.1172/JCI183697. eCollection 2025 Jun 16. J Clin Invest. 2025. PMID: 40338663 Free PMC article.
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities.
Ten Hacken E, Sewastianik T, Yin S, Hoffmann GB, Gruber M, Clement K, Penter L, Redd RA, Ruthen N, Hergalant S, Sholokhova A, Fell G, Parry EM, Broséus J, Guieze R, Lucas F, Hernández-Sánchez M, Baranowski K, Southard J, Joyal H, Billington L, Regis FFD, Witten E, Uduman M, Knisbacher BA, Li S, Lyu H, Vaisitti T, Deaglio S, Inghirami G, Feugier P, Stilgenbauer S, Tausch E, Davids MS, Getz G, Livak KJ, Bozic I, Neuberg DS, Carrasco RD, Wu CJ. Ten Hacken E, et al. Among authors: hernandez sanchez m. Blood Cancer Discov. 2023 Mar 1;4(2):150-169. doi: 10.1158/2643-3230.BCD-22-0082. Blood Cancer Discov. 2023. PMID: 36468984 Free PMC article.
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.
Thorvaldsdottir B, Mansouri L, Sutton LA, Nadeu F, Meggendorfer M, Parker H, Brieghel C, Laidou S, Moia R, Rossi D, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfò L, Mattsson M, Davis Z, Baliakas P, Rapado I, Miras F, Martinez-Lopez J, de la Serna J, Hernández Rivas JM, Larráyoz MJ, Calasanz MJ, Smedby KE, Espinet B, Puiggros A, Bullinger L, Bosch F, Tazón-Vega B, Baran-Marszak F, Oscier D, Nguyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hernández-Sánchez M, Pospisilova S, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R. Thorvaldsdottir B, et al. Among authors: hernandez sanchez m. Leukemia. 2025 Jul;39(7):1650-1660. doi: 10.1038/s41375-025-02615-5. Epub 2025 Apr 24. Leukemia. 2025. PMID: 40275070 Free PMC article.
High-Throughput CRISPR Screening in Hematological Neoplasms.
Ancos-Pintado R, Bragado-García I, Morales ML, García-Vicente R, Arroyo-Barea A, Rodríguez-García A, Martínez-López J, Linares M, Hernández-Sánchez M. Ancos-Pintado R, et al. Among authors: hernandez sanchez m. Cancers (Basel). 2022 Jul 25;14(15):3612. doi: 10.3390/cancers14153612. Cancers (Basel). 2022. PMID: 35892871 Free PMC article. Review.
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A, Rani L, Baliakas P, Foroughi-Asl H, Jylhä C, Skaftason A, Rapado I, Miras F, Martinez-Lopez J, de la Serna J, Rivas JMH, Thornton P, Larráyoz MJ, Calasanz MJ, Fésüs V, Mátrai Z, Bödör C, Smedby KE, Espinet B, Puiggros A, Gupta R, Bullinger L, Bosch F, Tazón-Vega B, Baran-Marszak F, Oscier D, Nguyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hernández-Sánchez M, Pospisilova S, Mills K, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R. Mansouri L, et al. Among authors: hernandez sanchez m. Leukemia. 2023 Feb;37(2):339-347. doi: 10.1038/s41375-022-01802-y. Epub 2022 Dec 24. Leukemia. 2023. PMID: 36566271 Free PMC article.
The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.
García-Vicente R, Rodríguez-García A, Ancos-Pintado R, Arroyo A, Ortega-Hernández A, Bragado-García I, Castellano E, Ortiz-Ruiz A, Navarro-Aguadero MÁ, Modrego J, Leivas A, García-Villalba R, Tomás-Barberán FA, Sánchez-Pina JM, Alonso R, Cedena MT, Hernández-Sánchez M, Carpio C, Barba P, Carbonell D, Kwon M, Bastos-Oreiro M, Martín García-Sancho A, Jiménez-Ubieto A, Valeri A, Gómez-Garre D, Martínez-López J, Linares M. García-Vicente R, et al. Among authors: hernandez sanchez m. Clin Cancer Res. 2026 Jan 16;32(2):375-389. doi: 10.1158/1078-0432.CCR-25-1676. Clin Cancer Res. 2026. PMID: 41231114 Free PMC article.
Pharmacoproteomics in the development of personalised medicine in Age-related Macular Degeneration (PHARPRO-AMD) study protocol.
Cañizo-Outeiriño A, Castro-Fernández DC, Arias-Barquet L, Fernández-Rodríguez MI, Olivier-Pascual N, Ortea I, Pastor-Iodate S, Rodríguez-De la Rúa-Franch E, Ruiz-Moreno JM, Ruiz-Moreno Ó, Sáenz de Viteri-Vázquez M, Sala-Puigdollers A; PHARPRO-AMD Study Group; Fernández-Ferreiro A. Cañizo-Outeiriño A, et al. BMJ Open Ophthalmol. 2025 Aug 24;10(1):e001956. doi: 10.1136/bmjophth-2024-001956. BMJ Open Ophthalmol. 2025. PMID: 40850787 Free PMC article.
SAMHD1 dysfunction impairs DNA damage response and increases sensitivity to PARP inhibition in chronic lymphocytic leukemia.
Rodríguez-Sánchez A, Quijada-Álamo M, Pérez-Carretero C, Herrero AB, Arroyo-Barea A, Dávila-Valls J, Rubio A, García de Coca A, Benito-Sánchez R, Rodríguez-Vicente AE, Hernández-Rivas JM, Hernández-Sánchez M. Rodríguez-Sánchez A, et al. Among authors: hernandez sanchez m. Sci Rep. 2025 Mar 26;15(1):10446. doi: 10.1038/s41598-025-93629-7. Sci Rep. 2025. PMID: 40140468 Free PMC article.
66 results